Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12275792
Antigen-binding proteins that activate the leptin receptor
granted -
US 12274747
Compositions and methods for treating cytokine release syndrome
granted -
US 12268730
Use of a VEGF antagonist to treat angiogenic eye disorders
granted -
US 12269897
Anti-PCSK9 antibodies
granted -
US 12269889
Human antibodies to the human glucagon receptor (HGCGR) and methods of use thereof to lower blood glucose or ketone levels
granted -
US 12264343
TCRa homing endonuclease variants
granted -
US 12264366
Genome-based methods for reducing cardiovascular risk
granted -
US 12256720
Humanized dipeptidyl-peptidase IV (DPP4) animals
granted -
US 12258412
Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 antibodies
granted -
US 12258627
Kelch domain containing 7B (KLHDC7B) variants and uses thereof
granted -
US 12258597
Methods and compositions for therapeutic protein delivery
granted -
US 12252544
Anti-CD63 antibodies, conjugates, and uses thereof
granted -
US 12252520
Myosin 15 promoters and uses thereof
granted -
US 12250931
Genetically modified mouse with a humanized PNPLA3 gene and methods of use
granted -
US 12251440
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments
granted -
US 12252530
Human antibodies to Fel d1 and methods of use thereof
granted -
US 12240907
N-terminal scFv multispecific binding molecules
granted -
US 12239687
Sustained release formulations using non-aqueous membrane emulsification
granted -
US 12240908
N-terminal scFv multispecific binding molecules
granted -
US 12234277
Hydrophobic interaction chromatography for viral clearance
granted -
US 12234460
Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
granted -
US 12227740
CBLB endonuclease variants, compositions, and methods of use
granted -
US 12230364
Immunotherapy methods for patients whose tumors carry a high passenger gene mutation burden
granted -
US 12214023
Compositions and methods for expressing factor IX
granted